proxyvotesnow.com

Home › Companies › HARVARD BIOSCIENCE INC. › 2023-2024

HARVARD BIOSCIENCE INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and HARVARD BIOSCIENCE INC.’s Form 8-K, filed 2024-05-14 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 3Ballot items
  • 122Asset managers
  • 515Fund votes
  • 2024-05-14Meeting date

Proxy season: 2023-2024

Explore HARVARD BIOSCIENCE INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by HARVARD BIOSCIENCE INC.

These tallies are HARVARD BIOSCIENCE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-14 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

HARVARD BIOSCIENCE INC. — official shareholder meeting results, meeting held 2024-05-14
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Alan Edrick 19,722,574---- 10,861,4974,292,458 Majority: yes
Proposal 2: Ratification of the Appointment of Grant Thornton LLP The Company's stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 34,794,99573,0038,531 ---- Majority: yes
Proposal 3: Approval, by Non-Binding Advisory Vote, of the Compensation of the Named Executive Officers The Company's stockholders approved the compensation of the Company's named executive officers, by a non-binding advisory vote: 27,472,149903,6082,208,314 --4,292,458 Majority: yes

Source: HARVARD BIOSCIENCE INC., Form 8-K, filed with the SEC on 2024-05-14 — read the filing on EDGAR.

How asset managers voted at the HARVARD BIOSCIENCE INC. 2023-2024 meeting

Each item below shows how the 122 asset managers that disclosed a HARVARD BIOSCIENCE INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. APPROVAL, BY A NON-BINDING ADVISORY VOTE, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 27,472,149AGAINST: 903,608

HARVARD BIOSCIENCE INC.’s own tally for this item (“Proposal 3: Approval, by Non-Binding Advisory Vote, of the Compensation of the Named Executive Officers The Company's stockholders approved the compensation of the Company's named executive officers, by a non-binding adv”): 27,472,149 for, 903,608 against, per its Form 8-K filed 2024-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 43,429,626 outstanding shares: 63% for, 2% against (65% of the company cast a for/against vote).

The 122 asset managers below cast 97% of the shares they voted on this item FOR (26,541,224 for, 811,635 against).

FOR 96%
FOR: 26,541,224 (96.1%)AGAINST: 811,635 (2.9%)UNKNOWN: 262,508 (1.0%)NOT VOTED: 4,700 (0.0%)
Largest asset managers voting on “APPROVAL, BY A NON-BINDING ADVISORY VOTE, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at HARVARD BIOSCIENCE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.2,916,7840 00For
BlackRock2,629,945497 00For
Harvey Partners, LLC2,557,5000 00For
Vanguard2,119,0340 00For
Dimensional1,859,8350 00For
Royce1,450,8290 00For
Granahan Investment Management, LLC1,416,1900 00For
Fidelity1,224,8690 00For
HEARTLAND ADVISORS INC866,4670 00For
HEARTLAND GROUP INC866,4670 00For
GEODE CAPITAL MANAGEMENT, LLC855,0850 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM682,8490 00For
Portolan Capital Management, LLC682,5350 00For
State Street672,4080 00For
Meros Investment Management, LP556,6590 00For
Charles Schwab459,5580 00For
Jackson National463,6000 00For
Northern Trust444,8620 00For
GREENWOOD CAPITAL ASSOCIATES LLC428,9700 00For
ACADIAN ASSET MANAGEMENT LLC365,6830 00For
Renaissance353,5790 00For
KENNEDY CAPITAL MANAGEMENT LLC189,045132,478 00For
Archon Capital Management LLC00 00Unknown
Victory Capital212,6410 00For
BRIDGEWAY CAPITAL MANAGEMENT, LLC0184,500 00Against

Showing the 25 largest of 122 asset managers. See all 122 in the interactive database.

2. Election of Director: Alan Edrick

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

64% Majority: yes · of votes cast

FOR 64%WITHHELD 36%
FOR: 19,722,574WITHHELD: 10,861,497

HARVARD BIOSCIENCE INC.’s own tally for this item (“Elect Director: Alan Edrick”): 19,722,574 for, 10,861,497 withheld, per its Form 8-K filed 2024-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 43,429,626 outstanding shares: 45.4% for, 25% withheld (70% of the company cast a for/withheld vote).

The 48 asset managers below cast 100% of the shares they voted on this item FOR (5,615,069 for, 0 against).

FOR 52.5%ABSTAIN 47.5%
FOR: 5,615,069 (52.5%)ABSTAIN: 5,072,294 (47.5%)UNKNOWN: 1,650 (0.0%)
Largest asset managers voting on “Election of Director: Alan Edrick” at HARVARD BIOSCIENCE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,042,3440 00For
Dimensional00 1,648,1160Abstain
Royce1,450,8290 00For
BlackRock00 1,350,2840Abstain
Fidelity811,9890 412,8700For
HEARTLAND GROUP INC866,4670 00For
Jackson National00 463,6000Abstain
Charles Schwab229,7790 00For
Victory Capital00 207,3890Abstain
BRIDGEWAY FUNDS INC00 177,5000Abstain
FORUM FUNDS II00 166,8570Abstain
TIAA00 139,9990Abstain
Northern Trust00 85,3410Abstain
Adirondack Funds82,5780 00For
QUANTITATIVE MASTER SERIES LLC00 74,0150Abstain
Equitable00 73,9880Abstain
WILSHIRE MUTUAL FUNDS INC00 45,5710Abstain
Goldman Sachs41,2690 00For
Lincoln Financial00 38,3690Abstain
Destra Investment Trust00 32,0570Abstain
Invesco22,8990 00For
WisdomTree22,2390 00For
John Hancock00 21,6650Abstain
Global X20,9730 00For
AIG/SunAmerica00 20,7800Abstain

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

3. TO RATIFY THE APPOINTMENT OF GRANT THORNTON LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 34,794,995AGAINST: 73,003

HARVARD BIOSCIENCE INC.’s own tally for this item (“Proposal 2: Ratification of the Appointment of Grant Thornton LLP The Company's stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal ye”): 34,794,995 for, 73,003 against, per its Form 8-K filed 2024-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 43,429,626 outstanding shares: 80% for, 0.2% against (80% of the company cast a for/against vote).

The 47 asset managers below cast 99.9% of the shares they voted on this item FOR (10,604,670 for, 115 against).

FOR 99.9%
FOR: 10,604,670 (100.0%)AGAINST: 115 (0.0%)UNKNOWN: 1,650 (0.0%)
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF GRANT THORNTON LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM” at HARVARD BIOSCIENCE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,042,3440 00For
Dimensional1,648,1160 00For
Royce1,450,8290 00For
BlackRock1,350,2840 00For
Fidelity1,224,8590 00For
HEARTLAND GROUP INC866,4670 00For
Jackson National463,6000 00For
Charles Schwab229,7790 00For
Victory Capital207,3890 00For
BRIDGEWAY FUNDS INC177,5000 00For
FORUM FUNDS II166,8570 00For
TIAA139,9990 00For
Northern Trust85,3410 00For
QUANTITATIVE MASTER SERIES LLC74,0150 00For
Equitable73,9880 00For
WILSHIRE MUTUAL FUNDS INC45,5710 00For
Goldman Sachs41,2690 00For
Lincoln Financial38,3690 00For
Destra Investment Trust32,0570 00For
Invesco22,8990 00For
WisdomTree22,2390 00For
John Hancock21,6650 00For
Global X20,9730 00For
AIG/SunAmerica20,7800 00For
Nationwide18,9750 00For

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

Largest HARVARD BIOSCIENCE INC. shareholders voting in 2023-2024

Ranked by the number of HARVARD BIOSCIENCE INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 43,429,626 shares outstanding at the time of that meeting.

Top HARVARD BIOSCIENCE INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 6.72%
2BlackRock 6.06%
3Harvey Partners, LLC 5.89%
4Vanguard 4.88%
5Dimensional 4.28%
6Royce 3.34%
7Granahan Investment Management, LLC 3.26%
8Fidelity 2.82%
9HEARTLAND ADVISORS INC 2.00%
10HEARTLAND GROUP INC 2.00%

Reported HARVARD BIOSCIENCE INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

HARVARD BIOSCIENCE INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
B. Riley Asset Management, LLC 6.77% DEF14A
Punch & Associates Investment Management, Inc. 6.72% DEF14A
Harvey Partners, LLC 5.89% DEF14A
James Green 5.28% DEF14A
Dimensional Fund Advisors 4.44% 13F
Vanguard Group 4.26% 13F
Geode Capital 1.97% 13F
Renaissance Technologies 1.62% 13F
State Street 1.60% 13F
BlackRock 1.43% 13F

Percentages above are of 43,429,626 shares outstanding, as reported by HARVARD BIOSCIENCE INC. on its Form 10-Q dated 2024-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from HARVARD BIOSCIENCE INC.’s 10-Q dated 2024-04-30. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At HARVARD BIOSCIENCE INC.'s shareholder meeting held 2024-05-14, in the 2023-2024 proxy season, 122 asset managers reported how they voted on 3 ballot items in their SEC Form N-PX filings, covering 515 separate fund positions. On the most widely held item on that ballot — APPROVAL, BY A NON-BINDING ADVISORY VOTE, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: HARVARD BIOSCIENCE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-14.

HARVARD BIOSCIENCE INC. proxy season coverage: 2023-2024 (this page).